PreprintAll rights reservedbioRxiv
Characterization of the knock-in AppSAA mouse model as a powerful tool for Alzheimer's disease preclinical research.
- 1The Jackson Laboratory
Related
- Concurrent cognitive, behavioral and systemic physiological features mark preclinical Alzheimer's disease
- Progress towards improving mouse models for preclinical testing of treatments for Alzheimer’s disease
- The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021–2025 State‐of‐the‐Art Review of Clinical and Preclinical Evidence
- Multimodal Connectomics Improves the Characterization of Alzheimer's Disease-Related Network Alterations
- Alzheimer’s disease research must connect vascular molecular phenotypes with physiology
BibTeX
@misc{garceau2026characterization,
title = {{Characterization of the knock-in AppSAA mouse model as a powerful tool for Alzheimer's disease preclinical research.}},
author = {D. T. Garceau and N. J. Ryan and J. Pomeroy-Tuck and R. Chidambaram and T. Ragan and R. S. PANDEY and G. W. Carter and A. L. Oblak and M. Sasner},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.08.750179},
url = {https://www.biorxiv.org/content/10.64898/2026.09.08.750179v1},
}
RIS
TY - UNPB
TI - Characterization of the knock-in AppSAA mouse model as a powerful tool for Alzheimer's disease preclinical research.
AU - D. T. Garceau
AU - N. J. Ryan
AU - J. Pomeroy-Tuck
AU - R. Chidambaram
AU - T. Ragan
AU - R. S. PANDEY
AU - G. W. Carter
AU - A. L. Oblak
AU - M. Sasner
PY - 2026
DA - 2026/09/08
PB - bioRxiv
DO - 10.64898/2026.09.08.750179
UR - https://www.biorxiv.org/content/10.64898/2026.09.08.750179v1
ER -